2025
Transparency in United States healthcare sustainability: a scoping review
Locke S, Hadley C, Sherman J, Hantel A, Senay E. Transparency in United States healthcare sustainability: a scoping review. Environmental Research Health 2025, 3: 022001. DOI: 10.1088/2752-5309/adb06d.Peer-Reviewed Original ResearchHealthcare sustainabilitySustainability initiativesEnvironmental sustainability practicesNon-peer-reviewed literatureHealth care administratorsBusiness of healthcareCorporate reportingPublic health impactIntegrate sustainabilitySustainable practicesScoping ReviewCare administratorsHealthcare literatureSustainability dataU.S. healthcareThematic analysisIndependent reviewersOvid MEDLINEHealthcareInclusion criteriaGreenwashingTransparent reportingBody of researchHealth impactsGrowing body of research
2024
PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA
Taggart T, Mathews A, Junious T, Lindsey J, Augustine A, Debnam C, Boyd Y, Wright S, Tucker J, Magnus M. PrEP your step: Implementing an online crowdsourcing contest to engage young people in HIV prevention in Washington DC, USA. PLOS ONE 2024, 19: e0313882. PMID: 39556546, PMCID: PMC11573147, DOI: 10.1371/journal.pone.0313882.Peer-Reviewed Original ResearchConceptsPrEP messagingSemi-structured interviewsHigh risk of HIVCommunity engagementCrowdsourced messagesYoung peopleCross-sectional surveyRisk of HIVPre-exposure prophylaxisPublic health impactImplementation researchPromote PrEPHIV preventionMedical providersConvenience sampleHIV incidenceCommunity partnersPromotion messagesEngaging young peopleWorld Health OrganizationThematic codingSurvey participantsPrEPHealth impactsSocial marketingEstimating the lives that could be saved by expanded access to weight-loss drugs
Pandey A, Ye Y, Wells C, Singer B, Galvani A. Estimating the lives that could be saved by expanded access to weight-loss drugs. Proceedings Of The National Academy Of Sciences Of The United States Of America 2024, 121: e2412872121. PMID: 39405358, PMCID: PMC11513960, DOI: 10.1073/pnas.2412872121.Peer-Reviewed Original ResearchConceptsGlucagon-like peptide-1Body mass index categoriesObesity prevalence dataGlucagon-like peptide-1 receptor agonistsHazard ratio of mortalityRatio of mortalityPublic health impactWeight loss drugsInsurance coverage issuesGastric inhibitory polypeptideHealthcare accessType 2 diabetesUnited StatesPublic health crisisObesity epidemicReceptor agonistsIndex categoriesHazard ratioPrevalence dataInhibitory polypeptidePeptide-1Health impactsNovel treatmentObesityHealth crisisPublic Health Impact of FDA’s Request for Additional Safety Data on Cytisine for Tobacco Cessation
Reddy K, Paltiel A, Freedberg K, Rigotti N. Public Health Impact of FDA’s Request for Additional Safety Data on Cytisine for Tobacco Cessation. JAMA Health Forum 2024, 5: e242647. PMID: 39177985, PMCID: PMC11344233, DOI: 10.1001/jamahealthforum.2024.2647.Peer-Reviewed Original ResearchConceptsPublic health benefitsCessation medicationsSmoking cessationStop smokingLife yearsLong-term abstinenceCivilian noninstitutionalized adultsTobacco cessation treatmentTobacco cessation medicationsPotential public health benefitsPopulation-level life expectancyLife expectancySmoking cessation medicationsLife expectancy gainsHealth benefitsPotential public health impactPublic health impactSmoking cessation aidTobacco cessationNoninstitutionalized adultsNoninstitutionalized populationMain OutcomesCessation treatmentCessation aidsYear of availabilityIntegrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder
Haque L, Leggio L. Integrated and collaborative care across the spectrum of alcohol-associated liver disease and alcohol use disorder. Hepatology 2024, 80: 1408-1423. PMID: 38935926, PMCID: PMC11841743, DOI: 10.1097/hep.0000000000000996.Peer-Reviewed Original ResearchAUD careAlcohol-associated liver diseaseAlcohol use disorderCollaborative careImpact of health disparitiesAlcohol-related deathsImpact of comorbid conditionsPublic health impactUse disorderHarm reduction approachesLiver diseaseInterprofessional teamHealth disparitiesTreatment of alcohol use disordersComprehensive careProblematic alcohol useSubstance use disordersSpectrum of alcohol-associated liver diseasesTreatment gapLiver-related outcomesMinority of patientsLiver-related morbidityAlcohol use disorder treatmentCareAlcohol useConducting Research at the Intersection of HCI and Health: Building and Supporting Teams with Diverse Expertise to Increase Public Health Impact
Agapie E, Karkar R, Aung T, Burgess E, Chinguwa M, Graham A, Klasnja P, Lyon A, McCall T, Munson S, Nunes F, Osterhage K. Conducting Research at the Intersection of HCI and Health: Building and Supporting Teams with Diverse Expertise to Increase Public Health Impact. 2024, 2024: 1-6. PMID: 38993629, PMCID: PMC11239082, DOI: 10.1145/3613905.3636298.Peer-Reviewed Original ResearchResearch and publication gaps on kratom and kratom products: a scoping review of current literature
Vicknasingam B, Karunakaran T, Chawarski M. Research and publication gaps on kratom and kratom products: a scoping review of current literature. Current Opinion In Psychiatry 2024, 37: 282-291. PMID: 38818826, DOI: 10.1097/yco.0000000000000950.Peer-Reviewed Original ResearchConceptsHealth system databasePublic health impactPublic health consequencesPrevalence ratesNational surveyHealth impactsPublic healthPublication gapSystem databaseCase series reportControlled clinical studiesClinical case reportEpidemiological factorsEpidemiological surveillanceCase reportScopus databasesSeries reportClinical studiesKratom productsSurveyHuman laboratoryResearch articlesKratomHealthAnalytical studyAssessing Direct and Spillover Effects of Intervention Packages in Network-randomized Studies
Buchanan A, Hernández-Ramírez R, Lok J, Vermund S, Friedman S, Forastiere L, Spiegelman D. Assessing Direct and Spillover Effects of Intervention Packages in Network-randomized Studies. Epidemiology 2024, 35: 481-488. PMID: 38709023, DOI: 10.1097/ede.0000000000001742.Peer-Reviewed Original ResearchIntervention packageEffectiveness of interventional packageImprove intervention deliveryPeer education interventionHIV prevention trialsPeer educator trainingMarginal structural modelsPublic health impactHIV risk behaviorsIntervention deliveryIntervention NetworkEducational interventionParticipant visitsPrevention trialsFollow-up visitRisk behaviorsHealth impactsInterventionEducational trainingParticipantsSpillover effectsVisitsHIVExposed networksPeerAlcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review
Rostam‐Abadi Y, Gholami J, Shadloo B, Aghaei A, Jobehdar M, Ardeshir M, Sangchooli A, Amin‐Esmaeili M, Taj M, Saeed K, Rahimi‐Movaghar A. Alcohol use, alcohol use disorder and heavy episodic drinking in the Eastern Mediterranean region: A systematic review. Addiction 2024, 119: 984-997. PMID: 38356084, DOI: 10.1111/add.16444.Peer-Reviewed Original ResearchConceptsAdult general populationGeneral populationAlcohol useEastern Mediterranean RegionWorld Health OrganizationAlcohol use disorderPrevalence of alcohol use disordersYoung general populationHealth OrganizationEastern Mediterranean countriesPatterns of alcohol usePublic health impactUse disorderHeavy episodic drinkingEstimates of alcoholAlcohol consumptionPooled prevalencePooled estimatesSystematic reviewHealth impactsEpisodic drinkingHeavy drinkingSubstance useTreatment-seeking peoplePrevalenceFeasibility of and reactivity to ecological momentary assessment (EMA) during electronic cigarette use initiation in adults who smoke daily MASKED FOR REVIEW
Hoeppner B, Eddie D, Schick M, Hoeppner S, Kelly L, Kelly J. Feasibility of and reactivity to ecological momentary assessment (EMA) during electronic cigarette use initiation in adults who smoke daily MASKED FOR REVIEW. The European Journal Of Psychiatry 2024, 38: 100247. PMID: 40124422, PMCID: PMC11927963, DOI: 10.1016/j.ejpsy.2023.100247.Peer-Reviewed Original ResearchEcological momentary assessmentMomentary assessmentE-cigarette useE-cigarette initiationEcological momentary assessment protocolEcological momentary assessment reportsE-cigarettesNicotine dependenceCohen's d valuesCigarette use initiationPublic health impactFollow-up weekMethods AdultsWeek 1ParticipantsAdultsPilot studyNon-significantRandomized groupsBiochemical assessmentExcellent adherenceAdherenceCigaretteAssessmentWeeksThe public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study
Schmit N, Topazian H, Natama H, Bellamy D, Traoré O, Somé M, Rouamba T, Tahita M, Bonko M, Sourabié A, Sorgho H, Stockdale L, Provstgaard-Morys S, Aboagye J, Woods D, Rapi K, Datoo M, Lopez F, Charles G, McCain K, Ouedraogo J, Hamaluba M, Olotu A, Dicko A, Tinto H, Hill A, Ewer K, Ghani A, Winskill P. The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study. The Lancet Infectious Diseases 2024, 24: 465-475. PMID: 38342107, DOI: 10.1016/s1473-3099(23)00816-2.Peer-Reviewed Original ResearchDisability-adjusted life yearsClinical malariaMalaria vaccineClinical casesVaccine introductionVaccinated childrenVaccine efficacyYears of follow-upPhase 2b trialPhase 3 trialSub-Saharan AfricaSurrogate of protectionIncremental costAntibody titresPublic health impactSerum Institute of IndiaBill &Cost-effectiveness ratioChildren Aged 2Dose pricesMalaria deathsMelinda Gates FoundationNIHR Oxford Biomedical Research CentreFollow-upUK Medical Research CouncilPragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation
Omerovic E, Petrie M, Redfors B, Fremes S, Murphy G, Marquis-Gravel G, Lansky A, Velazquez E, Perera D, Reid C, Smith J, van der Meer P, Lipsic E, Juni P, McMurray J, Bauersachs J, Køber L, Rouleau J, Doenst T. Pragmatic randomized controlled trials: strengthening the concept through a robust international collaborative network: PRIME-9—Pragmatic Research and Innovation through Multinational Experimentation. Trials 2024, 25: 80. PMID: 38263138, PMCID: PMC10807265, DOI: 10.1186/s13063-024-07935-y.Peer-Reviewed Original ResearchConceptsRandomized Controlled TrialsValue-based health careHealth policy decision-makingResearch priority settingQuality of healthcareHealthcare delivery systemValue-based healthcareDiverse practice settingsEffectiveness of interventionsPragmatic clinical trialsDiverse patient populationsPublic health impactEvidence-based medicineHealthcare qualityHealth outcomesHealth careHealthcare settingsDecision-making questionsPractice settingsPriority settingDecision-makingAlternative interventionsHealthcareStudy designPRCTsQuality of Life and Disability in Chikungunya Arthritis
Amaral J, Taylor P, Weinblatt M, Bandeira Í, Schoen R. Quality of Life and Disability in Chikungunya Arthritis. Current Rheumatology Reviews 2024, 20: 65-71. PMID: 37605393, DOI: 10.2174/1573397119666230726113647.Peer-Reviewed Original ResearchConceptsChikungunya arthritisVisual analog scaleSF-12Quality of lifeChikungunya feverVisual analog scale pain scoreShort Form Health SurveyHealth Assessment Questionnaire Disability IndexRetrospective cross-sectional studyVirus-infected patientsCKV patientsCross-sectional studyPublic health impactChikungunya fever patientsChikungunya virus infectionMCS-12PCS-12Assess disabilityOutbreak of chikungunya feverHealth SurveyDisability IndexPain scoresDAS28-ESRAnalog scaleMosquito vectors
2023
Including the term ‘tobacco-free nicotine’ in the nicotine addiction warning label mandated by the US Food and Drug Administration alters risk perceptions and use intentions
Morean M, Gueorguieva R, O'Malley S, Krishnan-Sarin S. Including the term ‘tobacco-free nicotine’ in the nicotine addiction warning label mandated by the US Food and Drug Administration alters risk perceptions and use intentions. Tobacco Control 2023, 34: 212-219. PMID: 37898544, PMCID: PMC11055938, DOI: 10.1136/tc-2023-058133.Peer-Reviewed Original ResearchWarning labelsParticipant characteristicsUS FoodMultivariable logistic regressionNicotine e-cigarettesPublic health impactAdministration altersMost harmAddictive chemicalNicotine productsNicotine addictionDrug AdministrationAnonymous online surveyE-cigarettesLogistic regressionNicotineYoung individualsVulnerable populationsHealth impactsFDAPublic healthRisk perceptionParticipantsSignificant interactionAddictivenessPublic Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials.
Kennedy-Shaffer L. Public Health Impacts of Vaccines for COVID-19 and Beyond: Opportunities to Overcome Technical and Regulatory Barriers for Randomized Trials. American Journal Of Public Health 2023, 113: 778-785. PMID: 37104734, PMCID: PMC10262256, DOI: 10.2105/ajph.2023.307302.Peer-Reviewed Original ResearchConceptsPublic health impactCOVID-19 pandemicPopulation healthEvidence baseCOVID-19Health impactsInfectious disease outbreaksCommunity levelRandomized trialsIndividual levelRegulatory barriersPivotal trialsClinical benefitTrialsClinical trialsVaccine trialsPrevent infectionStrategic deploymentVaccineHealthPrevalence and gender distribution of excoriation (skin-picking) disorder: A systematic review and meta-analysis
Farhat L, Reid M, Bloch M, Olfson E. Prevalence and gender distribution of excoriation (skin-picking) disorder: A systematic review and meta-analysis. Journal Of Psychiatric Research 2023, 161: 412-418. PMID: 37023597, PMCID: PMC11137851, DOI: 10.1016/j.jpsychires.2023.03.034.Peer-Reviewed Original ResearchConceptsExcoriation disorderPublic health impactEpidemiological studiesGeneral populationSystematic reviewHealth impactsDifferent prevalence estimatesPooled prevalenceOverall prevalenceInclusion criteriaMale ratioPubMed searchPrevalence estimatesGender distributionDisordersPrevalenceDatabase searchEMBASEReviewPopulationPubMedPsycINFOStudyWomen
2022
Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness
Burrows H, Antillón M, Gauld J, Kim J, Mogasale V, Ryckman T, Andrews J, Lo N, Pitzer V. Comparison of model predictions of typhoid conjugate vaccine public health impact and cost-effectiveness. Vaccine 2022, 41: 965-975. PMID: 36586741, PMCID: PMC9880559, DOI: 10.1016/j.vaccine.2022.12.032.Peer-Reviewed Original ResearchConceptsIncremental cost-effectiveness ratioRoutine vaccinationVaccine impactPublic health impactOne-time catchPotential public health impactHigh-incidence settingsTyphoid fever casesCost-effectiveness ratioMonths of ageHealth impactsModel-predicted outcomesPrimary outcomeChronic carriersIncidence settingsSymptomatic casesVaccine introductionEndemic settingsVaccine deploymentFever casesVaccinationTyphoid casesIncremental costTyphoid transmissionMonthsLongitudinal associations between flavored tobacco use and tobacco product cessation in a national sample of adults
Steeger CM, Harlow AF, Barrington-Trimis JL, Simon P, Hill KG, Leventhal AM. Longitudinal associations between flavored tobacco use and tobacco product cessation in a national sample of adults. Preventive Medicine 2022, 161: 107143. PMID: 35803351, PMCID: PMC9994601, DOI: 10.1016/j.ypmed.2022.107143.Peer-Reviewed Original ResearchConceptsTobacco productsTobacco useLower likelihoodFlavor useReduced likelihoodLong-term cessationShort-term abstinencePublic health impactTobacco product useWave 2Wave 4Adverse public health impactsReduced oddsHealth StudySociodemographic characteristicsAdult survey dataLong-term associationOlder adultsYoung adultsLongitudinal associationsCessationProduct useTwo yearsHealth impactsAdultsPrevalence and gender distribution of trichotillomania: A systematic review and meta-analysis
Thomson HA, Farhat LC, Olfson E, Levine JLS, Bloch MH. Prevalence and gender distribution of trichotillomania: A systematic review and meta-analysis. Journal Of Psychiatric Research 2022, 153: 73-81. PMID: 35802953, DOI: 10.1016/j.jpsychires.2022.06.058.Peer-Reviewed Original ResearchConceptsNoticeable hair lossHair-pulling behaviorOdds ratioHair lossPrevalence estimatesSystematic reviewGender distributionSignificant public health impactMental Disorders criteriaPublic health impactMale odds ratioFemale preponderanceEpidemiological studiesPrevalence dataUnderstudied conditionDisorder criteriaStatistical ManualTrichotillomaniaEpidemiological samplePrevalenceHealth impactsConsiderable heterogeneityDatabase searchAdditional researchFemalesThe balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants
Kim D, Keskinocak P, Pekgün P, Yildirim İ. The balancing role of distribution speed against varying efficacy levels of COVID-19 vaccines under variants. Scientific Reports 2022, 12: 7493. PMID: 35523832, PMCID: PMC9075929, DOI: 10.1038/s41598-022-11060-8.Peer-Reviewed Original ResearchConceptsOverall public health impactInfection attack rateCOVID-19 vaccineSARS-CoV-2Public health impactVaccine effectivenessAdverse outcomesMultiple vaccinesInitial efficacySuccessful immunization strategyImmunization strategiesVaccineLow-income countriesAttack rateEfficacyCOVID-19COVID-19 pandemicHealth impactsInfection spreadRecovered-deceased [SI(Q/F)RD] modelEfficacy levelsPandemicHospitalizationVaccinationVariants
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply